bluebird bio (BLUE)
(Delayed Data from NSDQ)
$0.91 USD
-0.01 (-1.13%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $0.91 0.00 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Income Statements
Fiscal Year end for bluebird bio, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 4 | 4 | 251 | 45 |
Cost Of Goods | NA | 10 | 39 | 5 | 3 |
Gross Profit | NA | -6 | -35 | 245 | 42 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 281 | 556 | 868 | 857 |
Income After Depreciation & Amortization | 0 | -287 | -591 | -623 | -815 |
Non-Operating Income | NA | 21 | 29 | 5 | 25 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -266 | -562 | -618 | -790 |
Income Taxes | NA | 0 | 0 | 1 | -1 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -267 | -563 | -619 | -790 |
Extras & Discontinued Operations | NA | 0 | -257 | 0 | 0 |
Net Income (GAAP) | NA | -267 | -819 | -619 | -790 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -282 | -571 | -604 | -797 |
Depreciation & Amortization (Cash Flow) | NA | 5 | 20 | 19 | 17 |
Income After Depreciation & Amortization | 0 | -287 | -591 | -623 | -815 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 78.59 | 68.19 | 62.18 | 55.19 |
Diluted EPS Before Non-Recurring Items | NA | -3.30 | -7.86 | -9.95 | -14.31 |
Diluted Net EPS (GAAP) | NA | -3.39 | -11.89 | -9.95 | -14.31 |
Fiscal Year end for bluebird bio, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | 12.39 | 6.89 | 2.38 |
Cost Of Goods | NA | NA | 10.96 | 9.56 | 3.38 |
Gross Profit | NA | NA | 1.44 | -2.67 | -0.99 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 86.16 | 82.62 | -9.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -84.72 | -85.29 | 8.45 |
Non-Operating Income | NA | NA | 13.00 | 12.31 | 12.80 |
Interest Expense | NA | NA | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | NA | -71.73 | -72.99 | 21.24 |
Income Taxes | NA | NA | 0.00 | -0.08 | 0.00 |
Minority Interest | NA | NA | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | NA | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | -71.73 | -72.91 | 21.24 |
Extras & Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | -71.73 | -72.91 | 21.24 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | 109.10 | 108.69 | 102.92 |
Diluted EPS Before Non-Recurring Items | NA | NA | -0.66 | -0.67 | 0.21 |
Diluted Net EPS (GAAP) | NA | NA | -0.66 | -0.67 | 0.21 |